missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18192384

LPAR1/LPA1/EDG-2 Antibody (OTI1G6), FITC, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-72519F

Product Code. 18192384

  • £660.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

LPAR1/LPA1/EDG-2 Monoclonal specifically detects LPAR1/LPA1/EDG-2 in Human, Mouse, Rat samples. It is validated for Flow Cytometry, Immunocytochemistry/Immunofluorescence.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

LPAR1/LPA1/EDG-2
Monoclonal
FITC
PBS with 0.05% Sodium Azide
LPAR1
Full length recombinant protein of human LPAR1/LPA1/EDG-2 (NP_001392) produced in HEK293T cells.
0.1 mL
Primary
Human, Mouse, Rat
IgG2b
Flow Cytometry, Immunocytochemistry, Immunofluorescence
OTI1G6
Flow Cytometry, Immunocytochemistry/Immunofluorescence
edg-2, EDG2Lysophosphatidic acid receptor Edg-2, endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor2,, Gpcr26, GPR26, LPA receptor 1, LPA-1, LPA1vzg-1, lysophosphatidic acid receptor 1, Mrec1.3, rec.1.3, ventricular zone gene 1, VZG1
Mouse
Affinity Purified
Apoptosis, GPCR, Signal Transduction
1902.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.